Re-Examination of 2017 ELN Risk Classification By a Cohort of 739 De Novoaml Patients in Taiwan: Co-Occurring Poor-Risk Mutations May Further Predict Outcome in FLT3-ITD Patients

MLA

Huang, Sheng-Chuan, et al. “Re-Examination of 2017 ELN Risk Classification By a Cohort of 739 De Novoaml Patients in Taiwan: Co-Occurring Poor-Risk Mutations May Further Predict Outcome in FLT3-ITD Patients.” Blood, vol. 132, no. 1, Number 1 Supplement 1, Nov. 2018, p. 3977. EBSCOhost, https://doi.org/10.1182/blood-2018-99-114315.

APA

Huang, S.-C., Hou, H.-A., Tsai, C.-H., Chou, W.-C., Tang, J.-L., Yao, M., Ko, B.-S., Tien, F.-M., Kuo, Y.-Y., Tseng, M.-H., Lin, C.-C., Lin, C.-T., Chuang, M.-K., Huang, T.-C., Chen, C.-Y., Hsu, S.-C., Cheng, C.-L., Huang, H.-H., Chou, S.-C., … Tien, H.-F. (2018). Re-Examination of 2017 ELN Risk Classification By a Cohort of 739 De Novoaml Patients in Taiwan: Co-Occurring Poor-Risk Mutations May Further Predict Outcome in FLT3-ITD Patients. Blood, 132(1, Number 1 Supplement 1), 3977. https://doi.org/10.1182/blood-2018-99-114315

Chicago

Huang, Sheng-Chuan, Hsin-An Hou, Cheng-Hong Tsai, Wen-Chien Chou, Jih-Luh Tang, Ming Yao, Bor-Sheng Ko, et al. 2018. “Re-Examination of 2017 ELN Risk Classification By a Cohort of 739 De Novoaml Patients in Taiwan: Co-Occurring Poor-Risk Mutations May Further Predict Outcome in FLT3-ITD Patients.” Blood 132 (1, Number 1 Supplement 1): 3977. doi:10.1182/blood-2018-99-114315.